Runben Biotechnology (SH:603193) Shang Hai Zheng Quan Bao·2025-10-20 20:05Core Viewpoint - The company reported a 19.28% year-on-year increase in revenue for the first three quarters of 2025, reaching RMB 1.238 billion, and a net profit attributable to the parent company of RMB 266 million, reflecting a 1.98% growth [66]. Group 1: Financial Data - The third quarter financial report is unaudited, and the company has confirmed the accuracy and completeness of the financial information [3][4]. - The company plans to use up to RMB 650 million of temporarily idle raised funds for cash management, which is expected to enhance fund utilization efficiency without affecting ongoing projects [30][32][70]. Group 2: Product and Price Changes - The average selling price of the mosquito repellent product series increased year-on-year in Q3 2025 due to changes in product structure [8]. - The average price of surfactants rose by RMB 1.32 per kilogram (9.04% increase) compared to Q3 2024, while functional additives saw an increase of RMB 23.69 per kilogram (9.01% increase) [9][11]. Group 3: Shareholder Meeting - The company will hold its third extraordinary general meeting on November 5, 2025, to discuss various proposals, including the approval of the financial audit firm and the use of idle funds [52][70].